| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/24/2014 | US20140206700 Chemical compounds |
| 07/24/2014 | US20140206691 Cyclic protein tyrosine kinase inhibitors |
| 07/24/2014 | US20140206689 Modulators of atp-binding cassette transporters |
| 07/24/2014 | US20140206681 Btk inhibitors |
| 07/24/2014 | US20140206678 Inhibitors of mtor kinase as anti -viral agent |
| 07/24/2014 | US20140206676 Substituted 4-(1h-pyrazol-4-yl)benzyl analogues as positive allosteric modulators of machr m1 receptors |
| 07/24/2014 | US20140206670 Combinations comprising alpha-2-delta ligands |
| 07/24/2014 | US20140206661 Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditions |
| 07/24/2014 | US20140206654 Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ |
| 07/24/2014 | US20140206649 Cannabinoid receptor modulators |
| 07/24/2014 | US20140206648 Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
| 07/24/2014 | US20140206642 Methods of use of biomaterial and injectable implant containing biomaterial |
| 07/24/2014 | US20140206641 Remedy |
| 07/24/2014 | US20140206640 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
| 07/24/2014 | US20140206636 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 07/24/2014 | US20140206625 Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions |
| 07/24/2014 | US20140206624 Treatment of leukemia |
| 07/24/2014 | US20140206622 Stable peptide-based pace4 inhibitors |
| 07/24/2014 | US20140206618 Inhibitors of the Renal Outer Medullary Potassium Channel |
| 07/24/2014 | US20140206615 Glp-1 agonist and cardiovascular complications |
| 07/24/2014 | US20140206609 Functionalized Exendin-4 Derivatives |
| 07/24/2014 | US20140206608 Exendin-4 Derivatives |
| 07/24/2014 | US20140205680 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
| 07/24/2014 | US20140205679 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy |
| 07/24/2014 | US20140205669 dhS1P AND USE OF SAME AS AN ANTICANCER THERAPEUTIC AND IMMUNOMODULATOR |
| 07/24/2014 | US20140205655 OLIGOOXOPIPERAZINES FOR p53 REACTIVATION |
| 07/24/2014 | US20140205643 Use of alginate oligomers in combating biofilms |
| 07/24/2014 | US20140205603 Siglec-15 antibodies in treating bone loss-related disease |
| 07/24/2014 | US20140205602 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 07/24/2014 | US20140205599 Polypeptide that binds aberrant cells and induces apoptosis |
| 07/24/2014 | US20140205596 Organic compounds |
| 07/24/2014 | US20140205595 Compounds and methods of prophylaxis and treatment regarding nicotinic receptor antagonists |
| 07/24/2014 | US20140205589 New stable anesthetic composition for reducing skin reactions |
| 07/24/2014 | US20140205588 Plasminogen and plasmin variants |
| 07/24/2014 | US20140205584 Anti-tnf-alpha therapy for the mucopolysaccharidoses and other lysosomal disorders |
| 07/24/2014 | US20140205569 Methods and compositions for preventing and treating osteoarthritis |
| 07/24/2014 | US20140205567 Macrocyclic Heterocyclic Compound for Inhibiting Hepatitis C Virus and Preparation and Use Thereof |
| 07/24/2014 | US20140205566 Cyclic nucleuoside derivatives and uses thereof |
| 07/24/2014 | US20140205565 Compositions and Methods for Treating Organ Dysfunction |
| 07/24/2014 | US20140205564 Hepatitis C Virus Inhibitors |
| 07/24/2014 | US20140205562 Il-1 binding proteins |
| 07/24/2014 | US20140205559 Antifungal compositions for the treatment of skin and nails |
| 07/24/2014 | US20140205558 Sodium thiosulfate-containing pharmaceutical compositions |
| 07/24/2014 | US20140205544 Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine |
| 07/24/2014 | US20140205542 Perfusive Organ Hemostasis |
| 07/23/2014 | EP2755689A1 Methods for treating hcv |
| 07/23/2014 | EP2755680A1 Particluate vaccine formulations |
| 07/23/2014 | EP2755661A1 Compositions for treating bone diseases and broken bones |
| 07/23/2014 | EP2755653A1 Compositions and methods for treating cancer using pi3k beta inhibitor and mapk pathway inhibitor, including mek and raf inhibitors |
| 07/23/2014 | EP2755644A1 Combinations comprising a s1p receptor modulator |
| 07/23/2014 | CN1638751B 叶酸盐在制备用于预防和治疗炎症和炎症相关性疾病的药物制剂中的用途 Folate in the manufacture of pharmaceutical preparations for the prevention and treatment of inflammation and inflammation-related diseases in the use of |
| 07/23/2014 | CN103945868A 骨生成促进剂 Osteogenesis-promoting agent |
| 07/23/2014 | CN103945850A 磷酸肌醇-3-激酶抑制剂与Janus激酶2-信号转导和转录激活因子5通路的调节剂的组合 Phosphate 3-kinase inhibitor, in combination with the Janus kinase 2- signal transduction and activator of transcription 5 pathway modulators |
| 07/23/2014 | CN103945840A 糖尿病性心血管并发症的预防/治疗剂 Prevention of diabetic cardiovascular complications / therapeutic agent |
| 07/23/2014 | CN103937877A 对alk抑制剂具有先抗性或后抗性癌症的识别，判断和治疗 Alk identification of inhibitors after the first resistant or resistant cancer, the determination and treatment |
| 07/23/2014 | CN103937872A Crm1在胃癌诊断与治疗中的应用 Crm1 application in the diagnosis and treatment of gastric cancer |
| 07/23/2014 | CN103937871A Srrp35基因和表达产物在癌症诊断与治疗中的应用 Srrp35 gene expression products and applications in cancer diagnosis and treatment |
| 07/23/2014 | CN103936945A 一类新型高效抗肿瘤靶向药物载体及其制备方法 A new class of highly active anti-tumor targeting drug carrier and its preparation method |
| 07/23/2014 | CN103936829A 多肽和靶向药物载体及制备方法以及药物组合物及其制备方法 Peptides and targeted drug carriers and preparation methods and pharmaceutical compositions and preparation method |
| 07/23/2014 | CN103933578A miRNA-185的应用和含有其的药物组合物 miRNA-185 applications and pharmaceutical compositions containing them |
| 07/23/2014 | CN103933575A 一种三齿型连接子及其应用 A three-tooth type connector and its application |
| 07/23/2014 | CN103933573A 用于治疗免疫病症的联合治疗 Combination therapy for the treatment of immune disorders |
| 07/23/2014 | CN103933572A 治疗疼痛和瘙痒的方法、组合物和试剂盒 The treatment of pain and itching of the methods, compositions, and kits |
| 07/23/2014 | CN103933571A 一种减肥瘦身液 A weight loss of thin liquid |
| 07/23/2014 | CN103933570A S1p受体调节剂的给药方案 Regimen S1p receptor modulators |
| 07/23/2014 | CN103933569A 一种抗肺癌药物组合物及其应用、药盒和包装件 An anti-cancer pharmaceutical composition and its applications, kits and packages |
| 07/23/2014 | CN103933567A 用于治疗炎症的组合物和方法 The compositions and methods for treating inflammation |
| 07/23/2014 | CN102908351B 用于治疗糖尿病的二肽基肽酶抑制剂 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 07/23/2014 | CN102370983B 一种抗肿瘤药物组合物及其用途 One kind of antitumor compositions and uses thereof |
| 07/23/2014 | CN101766547B 单糖与抗氧化剂的组合及其美容学应用 Its combination of monosaccharides and cosmetology application of antioxidants |
| 07/23/2014 | CN101653354B 化学物质的无创测量 Noninvasive measurement of chemical substances |
| 07/22/2014 | US8788212 Compositions and methods for biological remodeling with frozen particle compositions |
| 07/22/2014 | US8785635 Cyclopamine analogs |
| 07/22/2014 | US8785617 Oligomeric compounds for the modulation of HIF-1A expression |
| 07/22/2014 | US8785478 Viral polymerase inhibitors |
| 07/22/2014 | US8785447 Use of dopamine D3 receptor ligands for the production of drugs for treating renal function disorders |
| 07/22/2014 | US8785423 Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases |
| 07/22/2014 | US8785419 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 07/22/2014 | US8785387 Neuregulin based methods and compositions for treating cardiovascular disease |
| 07/22/2014 | US8785377 Tetrazolyl macrocyclic hepatitis C serine protease inhibitors |
| 07/22/2014 | US8785372 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 07/22/2014 | US8784862 Compounds and method for coating surfaces in a hemocompatible manner |
| 07/22/2014 | US8784825 Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC |
| 07/22/2014 | US8784809 Vascular endothelial growth factor 2 |
| 07/22/2014 | US8784796 Vaccine immunotherapy for treating hepatocellular cancer in immune suppressed patients |
| 07/22/2014 | CA2412845C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 07/22/2014 | CA2405299C Method of treatment using ligand-immunogen conjugates |
| 07/22/2014 | CA2388562C Mammalian cytokines; related reagents and methods |
| 07/22/2014 | CA2383774C Fibroblast growth factor-like polypeptides |
| 07/17/2014 | WO2014108872A1 Compositions and methods for treating bacterial infections |
| 07/17/2014 | US20140200271 Antitussive compositions comprising memantine |
| 07/17/2014 | US20140200252 Crystal forms of saxagliptin |
| 07/17/2014 | US20140200251 Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties |
| 07/17/2014 | US20140200250 Anti-cancer agents |
| 07/17/2014 | US20140200246 Compounds for the treatment of conditions associated with dgat1 activity |
| 07/17/2014 | US20140200243 Treatment of crohn's disease with laquinimod |
| 07/17/2014 | US20140200238 Drug treatment of overactive bladder |
| 07/17/2014 | US20140200236 Opioid agonist/antagonist combinations |
| 07/17/2014 | US20140200234 Adjuvant chemotherapy for anaplastic gliomas |
| 07/17/2014 | US20140200226 Anti-malarial compounds from marine natural products |